Showing results (81-90 of 187) with videos related to
Sort By:
Pageof 19
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 22, 2022
Effective CMV prophylaxis with high-dose valaciclovir in allogeneic hematopoietic stem-cell recipients at a high risk of CMV infectionGenevieve Douglas, Michelle K Yong, Shio Yen Tio, et al.Leukemia & Lymphoma|December 18, 2025
Reduced burden of infection with consecutive day dosing of high dose cytarabine consolidation versus conventional dosing for acute myeloid leukemiaAlice J Liu, Emily Batterham, Rithin Nedumannil, et al.Haematologica|June 1, 2005
Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignanciesConstantine Tam, John F Seymour, Michael Brown, et al.Trials|October 21, 2015
The Patient Remote Intervention and Symptom Management System (PRISMS) - a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trialSibilah Breen, David Ritchie, Penelope Schofield, et al.Internal Medicine Journal|August 2, 2023
Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantationAshley McEwan, Matthew Greenwood, Christopher Ward, et al.International Journal of Cancer|July 31, 2025
Developing evidence-based cancer prevention recommendations: Methodology of the World Code Against Cancer Framework to create region-specific codesCarolina Espina, David Ritchie, Ariadna Feliu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2014
Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantationPhilip A Thompson, Andrew Lim, Yvonne Panek-Hudson, et al.Leukemia & Lymphoma|July 26, 2016
Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyureaGenevieve Douglas, Claire Harrison, Cecily Forsyth, et al.Annals of Hematology|July 28, 2018
The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipientsAbbey Willcox, Eric Wong, Christa Nath, et al.European Journal of Public Health|April 12, 2023
Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countriesMeritxell Mallafré-Larrosa, David Ritchie, Ginevra Papi, et al.Pageof 19